Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Brown Jason Parker | Chief Financial Officer | 12 | $0 | $0 | 2024-03-18 |
| Torres Denice | Director | 10 | $0 | $0 | 2024-03-18 |
| Kane William P Jr | Chief Commercial Officer | 8 | $0 | $0 | 2024-03-18 |
| Wheadon David E. | Director | 10 | $0 | $0 | 2024-03-18 |
| Miller Andrew Craig | President of R&D | 150 | $0 | $44.46M | 2024-03-18 |
| Brannan Stephen K. | Chief Medical Officer | 188 | $0 | $40.28M | 2024-03-18 |
| Pande Atul | Director | 74 | $0 | $7.50M | 2024-03-18 |
| OLSON LAURIE J | Director | 39 | $0 | $1.88M | 2024-03-18 |
| Meury William | President and CEO | 8 | $0 | $0 | 2024-03-18 |
| HEALY JAMES | Director | 40 | $45.82M | $1.20M | 2024-03-18 |
| PAUL STEVEN M | President & CEO | 50 | $480.7K | $30.24M | 2024-03-18 |
| COUGHLIN CHRISTOPHER J | Director | 15 | $0 | $0 | 2024-03-18 |
| JONAS JEFFREY M | Director | 32 | $0 | $8.29M | 2024-03-18 |
| Ignelzi Troy A. | Chief Financial Officer | 144 | $0 | $25.79M | 2023-08-22 |
| Lykins Charmaine | Chief Commercial Officer | 1 | $0 | $0 | 2021-11-29 |
| Preston Heather | Director | 15 | $420.4K | $0 | 2021-06-24 |
| ARCH Venture Partners IX Overage, L.P. | 10% Owner | 4 | $0 | $0 | 2021-04-13 |
| NELSEN ROBERT | Director, 10% Owner | 21 | $3.20M | $0 | 2021-04-13 |
| PureTech Health LLC | Other | 11 | $0 | $465.54M | 2021-02-09 |
| BYBEE CLINTON | 10% Owner | 14 | $3.20M | $0 | 2021-01-08 |
| ARCH Venture Fund IX Overage, L.P. | 10% Owner | 4 | $0 | $0 | 2020-11-12 |
| HARRIGAN EDMUND | Director | 6 | $0 | $4.52M | 2020-08-12 |
| Alexandria Venture Investments, LLC | 10% Owner | 3 | $480.0K | $0 | 2019-07-02 |
| CHOWRIRA BHARAT M | Director | 2 | $212.2K | $0 | 2019-07-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 10,306 | $330.00 | $3.40M | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 4,677 | $324.55 | $1.52M | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 6,362 | $320.80 | $2.04M | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 50,000 | $230.28 | $11.51M | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 12,837 | $198.36 | $2.55M | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 37,813 | $218.03 | $8.24M | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 17,350 | $142.74 | $2.48M | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 7,696 | $160.91 | $1.24M | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 7,100 | $138.21 | $981.3K | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 10,312 | $218.03 | $2.25M | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 6,562 | $198.36 | $1.30M | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 3,281 | $230.28 | $755.5K | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 10,306 | $330.00 | $3.40M | 0 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 25,000 | $243.35 | $6.08M | 0 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 976 | $136.81 | $133.5K | 0 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 12,500 | $232.41 | $2.91M | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 19,893 | $322.73 | $6.42M | 0 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 16,250 | $314.00 | $5.10M | 0 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 12,500 | $232.41 | $2.91M | 0 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 29,937 | $137.85 | $4.13M | 0 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | D To issuer deriv | 2024-03-18 | 2024-03-18 | 10,306 | $330.00 | $3.40M | 0 | SEC↗ |
| Meury William | President and CEO | D To issuer deriv | 2024-03-18 | 2024-03-18 | 63,065 | $136.81 | $8.63M | 0 | SEC↗ |
| Meury William | President and CEO | D To issuer deriv | 2024-03-18 | 2024-03-18 | 38,688 | $330.00 | $12.77M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 66,900 | $198.36 | $13.27M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 70,000 | $230.28 | $16.12M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 231,992 | $320.80 | $74.42M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 11,578 | $322.73 | $3.74M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 47,817 | $327.08 | $15.64M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 15,855 | $330.00 | $5.23M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 25,100 | $142.74 | $3.58M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer deriv | 2024-03-18 | 2024-03-18 | 73,250 | $218.03 | $15.97M | 0 | SEC↗ |
| OLSON LAURIE J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| OLSON LAURIE J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| OLSON LAURIE J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| OLSON LAURIE J | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 13,000 | $245.14 | $3.19M | 0 | SEC↗ |
| Pande Atul | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 12,500 | $232.41 | $2.91M | 0 | SEC↗ |
| Pande Atul | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| Pande Atul | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| Pande Atul | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 616,703 | $314.00 | $193.64M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 136,094 | $322.96 | $43.95M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 757,045 | $322.73 | $244.32M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 449,463 | $320.80 | $144.19M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 87,494 | $320.80 | $28.07M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 15,205 | $320.80 | $4.88M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 71,121 | $309.98 | $22.05M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 135,992 | $230.28 | $31.32M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 161,850 | $198.36 | $32.10M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 146,900 | $218.03 | $32.03M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 22,800 | $142.74 | $3.25M | 0 | SEC↗ |
| Torres Denice | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| Torres Denice | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| Torres Denice | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| Torres Denice | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 25,000 | $225.74 | $5.64M | 0 | SEC↗ |
| Wheadon David E. | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| Wheadon David E. | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 25,000 | $235.44 | $5.89M | 0 | SEC↗ |
| Wheadon David E. | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| Wheadon David E. | Director | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer | 2024-03-18 | 2024-03-18 | 36,117 | $330.00 | $11.92M | 6,487 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | D To issuer | 2024-03-18 | 2024-03-18 | 6,487 | $330.00 | $2.14M | 0 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer | 2024-03-18 | 2024-03-18 | 14,009 | $330.00 | $4.62M | 7,158 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | D To issuer | 2024-03-18 | 2024-03-18 | 7,158 | $330.00 | $2.36M | 0 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer | 2024-03-18 | 2024-03-18 | 683 | $330.00 | $225.4K | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer | 2024-03-18 | 2024-03-18 | 1,372,441 | $330.00 | $452.91M | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer | 2024-03-18 | 2024-03-18 | 8,025 | $330.00 | $2.65M | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| HEALY JAMES | Director | D To issuer | 2024-03-18 | 2024-03-18 | 32,500 | $330.00 | $10.72M | 990 | SEC↗ |
| JONAS JEFFREY M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | D To issuer | 2024-03-18 | 2024-03-18 | 5,000 | $330.00 | $1.65M | 8,828 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | D To issuer | 2024-03-18 | 2024-03-18 | 8,828 | $330.00 | $2.91M | 0 | SEC↗ |
| Meury William | President and CEO | D To issuer | 2024-03-18 | 2024-03-18 | 10,342 | $330.00 | $3.41M | 19,037 | SEC↗ |
| Meury William | President and CEO | D To issuer | 2024-03-18 | 2024-03-18 | 19,037 | $330.00 | $6.28M | 0 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer | 2024-03-18 | 2024-03-18 | 13,977 | $330.00 | $4.61M | 9,412 | SEC↗ |
| Miller Andrew Craig | President of R&D | D To issuer | 2024-03-18 | 2024-03-18 | 9,412 | $330.00 | $3.11M | 0 | SEC↗ |
| OLSON LAURIE J | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| Pande Atul | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 8,550 | $330.00 | $2.82M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 30,304 | $330.00 | $10.00M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 10,000 | $330.00 | $3.30M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 33,882 | $330.00 | $11.18M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 30,304 | $330.00 | $10.00M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 35,877 | $330.00 | $11.84M | 0 | SEC↗ |
| PAUL STEVEN M | Director | D To issuer | 2024-03-18 | 2024-03-18 | 2,046 | $330.00 | $675.2K | 8,550 | SEC↗ |
| Torres Denice | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| Wheadon David E. | Director | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-03-08 | 2024-03-11 | 1,791 | — | $0 | 37,813 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-03-08 | 2024-03-11 | 3,209 | — | $0 | 12,837 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-03-08 | 2024-03-11 | 2,500 | — | $0 | 4,677 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2024-03-08 | 2024-03-11 | 100 | $318.96 | $31.9K | 42,604 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2024-03-08 | 2024-03-11 | 4,900 | $318.33 | $1.56M | 42,704 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-03-08 | 2024-03-11 | 1,791 | $111.97 | $200.5K | 47,604 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-03-08 | 2024-03-11 | 3,209 | $131.64 | $422.4K | 45,813 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-03-08 | 2024-03-11 | 2,500 | $5.45 | $13.6K | 42,604 | SEC↗ |
| PAUL STEVEN M | Director | G Gift | 2024-03-04 | 2024-03-04 | 30,304 | — | $0 | 2,364 | SEC↗ |
| PAUL STEVEN M | Director | G Gift | 2024-03-04 | 2024-03-04 | 30,304 | — | $0 | 30,304 | SEC↗ |
| PAUL STEVEN M | Director | G Gift | 2024-03-01 | 2024-03-04 | 30,304 | — | $0 | 40,304 | SEC↗ |
| PAUL STEVEN M | Director | G Gift | 2024-03-01 | 2024-03-04 | 30,304 | — | $0 | 30,304 | SEC↗ |
| PAUL STEVEN M | Director | G Gift | 2024-03-01 | 2024-03-04 | 30,304 | — | $0 | 10,000 | SEC↗ |
| PAUL STEVEN M | Director | G Gift | 2024-03-01 | 2024-03-04 | 30,304 | — | $0 | 32,668 | SEC↗ |
| PAUL STEVEN M | Director | J Other | 2024-02-29 | 2024-03-04 | 47,378 | $315.18 | $14.93M | 70,608 | SEC↗ |
| PAUL STEVEN M | Director | M Exercise deriv | 2024-02-23 | 2024-02-26 | 27,510 | — | $0 | 757,045 | SEC↗ |
| PAUL STEVEN M | Director | M Exercise deriv | 2024-02-23 | 2024-02-26 | 4,008 | — | $0 | 135,992 | SEC↗ |
| PAUL STEVEN M | Director | M Exercise | 2024-02-23 | 2024-02-26 | 27,510 | $7.27 | $200.0K | 38,106 | SEC↗ |
| PAUL STEVEN M | Director | M Exercise | 2024-02-23 | 2024-02-26 | 4,008 | $99.72 | $399.7K | 42,114 | SEC↗ |
| Meury William | President and CEO | A Award deriv | 2024-02-13 | 2024-02-15 | 38,688 | — | $0 | 38,688 | SEC↗ |
| Miller Andrew Craig | President of R&D | A Award deriv | 2024-02-13 | 2024-02-15 | 15,855 | — | $0 | 15,855 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | A Award deriv | 2024-02-13 | 2024-02-15 | 10,306 | — | $0 | 10,306 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | A Award deriv | 2024-02-13 | 2024-02-15 | 10,306 | — | $0 | 10,306 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | A Award deriv | 2024-02-13 | 2024-02-15 | 10,306 | — | $0 | 10,306 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | F Tax w/h | 2024-02-13 | 2024-02-15 | 278 | $318.00 | $88.4K | 21,167 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | F Tax w/h | 2024-02-09 | 2024-02-12 | 1,046 | $317.14 | $331.7K | 40,104 | SEC↗ |
| Miller Andrew Craig | President of R&D | F Tax w/h | 2024-02-09 | 2024-02-12 | 1,011 | $317.14 | $320.6K | 23,389 | SEC↗ |
| PAUL STEVEN M | Director | F Tax w/h | 2024-02-09 | 2024-02-12 | 804 | $317.14 | $255.0K | 10,596 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-02-08 | 2024-02-12 | 2,500 | — | $0 | 7,177 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-02-08 | 2024-02-12 | 5,000 | — | $0 | 39,604 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2024-02-08 | 2024-02-12 | 4,182 | $316.05 | $1.32M | 41,968 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-02-08 | 2024-02-12 | 5,000 | $111.97 | $559.9K | 46,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-02-08 | 2024-02-12 | 2,500 | $5.45 | $13.6K | 41,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2024-02-08 | 2024-02-12 | 818 | $316.56 | $258.9K | 41,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-01-08 | 2024-01-09 | 5,304 | — | $0 | 16,046 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-01-08 | 2024-01-09 | 2,500 | — | $0 | 9,677 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2024-01-08 | 2024-01-09 | 9,696 | — | $0 | 44,604 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-01-08 | 2024-01-09 | 5,304 | $131.64 | $698.2K | 43,954 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-01-08 | 2024-01-09 | 2,500 | $5.45 | $13.6K | 38,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2024-01-08 | 2024-01-09 | 9,696 | $111.97 | $1.09M | 53,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2024-01-08 | 2024-01-09 | 15,000 | $316.81 | $4.75M | 38,650 | SEC↗ |
| Meury William | President and CEO | F Tax w/h | 2023-12-28 | 2023-12-29 | 8,694 | $316.30 | $2.75M | 29,379 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | F Tax w/h | 2023-12-28 | 2023-12-29 | 3,828 | $316.30 | $1.21M | 13,828 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-12-08 | 2023-12-12 | 2,500 | — | $0 | 12,177 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-12-08 | 2023-12-12 | 10,000 | — | $0 | 21,350 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-12-08 | 2023-12-12 | 99 | $204.18 | $20.2K | 36,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-12-08 | 2023-12-12 | 2,251 | $203.80 | $458.8K | 36,249 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-12-08 | 2023-12-12 | 3,969 | $202.74 | $804.7K | 38,500 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-12-08 | 2023-12-12 | 2,116 | $201.73 | $426.9K | 42,469 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-12-08 | 2023-12-12 | 1,565 | $200.11 | $313.2K | 44,585 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-12-08 | 2023-12-12 | 10,000 | $131.64 | $1.32M | 46,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-12-08 | 2023-12-12 | 2,500 | $5.45 | $13.6K | 36,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-11-08 | 2023-11-13 | 2,500 | — | $0 | 14,677 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-11-08 | 2023-11-13 | 5,000 | — | $0 | 31,350 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-11-08 | 2023-11-13 | 265 | $177.14 | $46.9K | 36,703 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-11-08 | 2023-11-13 | 2,500 | $5.45 | $13.6K | 33,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-11-08 | 2023-11-13 | 2,245 | $180.08 | $404.3K | 33,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-11-08 | 2023-11-13 | 808 | $178.90 | $144.6K | 35,895 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-11-08 | 2023-11-13 | 401 | $175.69 | $70.5K | 36,968 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-11-08 | 2023-11-13 | 1,281 | $174.11 | $223.0K | 37,369 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-11-08 | 2023-11-13 | 5,000 | $131.64 | $658.2K | 38,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-10-09 | 2023-10-10 | 5,000 | — | $0 | 36,350 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-10-09 | 2023-10-10 | 2,500 | — | $0 | 17,177 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-10-09 | 2023-10-10 | 1,744 | $173.77 | $303.1K | 31,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-10-09 | 2023-10-10 | 2,500 | $5.45 | $13.6K | 31,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-10-09 | 2023-10-10 | 5,000 | $131.64 | $658.2K | 36,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-10-09 | 2023-10-10 | 3,256 | $172.96 | $563.2K | 32,894 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | A Award deriv | 2023-09-29 | 2023-10-03 | 7,696 | — | $0 | 7,696 | SEC↗ |
| Brown Jason Parker | Chief Financial Officer | A Award | 2023-09-29 | 2023-10-03 | 4,496 | — | $0 | 21,445 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-09-08 | 2023-09-11 | 2,500 | — | $0 | 19,677 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-09-08 | 2023-09-11 | 5,000 | — | $0 | 41,350 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-09-08 | 2023-09-11 | 5,000 | $131.64 | $658.2K | 33,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-09-08 | 2023-09-11 | 2,500 | $5.45 | $13.6K | 28,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-09-08 | 2023-09-11 | 60 | $185.60 | $11.1K | 28,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-09-08 | 2023-09-11 | 908 | $185.03 | $168.0K | 28,710 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-09-08 | 2023-09-11 | 2,756 | $184.13 | $507.5K | 29,618 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-09-08 | 2023-09-11 | 1,276 | $183.07 | $233.6K | 32,374 | SEC↗ |
| JONAS JEFFREY M | Director | M Exercise deriv | 2023-09-01 | 2023-09-05 | 13,809 | — | $0 | 19,893 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-09-01 | 2023-09-05 | 600 | $186.34 | $111.8K | 14,199 | SEC↗ |
| JONAS JEFFREY M | Director | M Exercise | 2023-09-01 | 2023-09-05 | 13,809 | $7.27 | $100.4K | 14,799 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-09-01 | 2023-09-05 | 8,423 | $188.34 | $1.59M | 1,389 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-09-01 | 2023-09-05 | 4,387 | $187.26 | $821.5K | 9,812 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-09-01 | 2023-09-05 | 399 | $188.98 | $75.4K | 990 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2023-08-22 | 2023-08-24 | 1,500 | — | $0 | 93,226 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-08-22 | 2023-08-24 | 60 | $176.60 | $10.6K | 30,487 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-08-22 | 2023-08-24 | 505 | $175.59 | $88.7K | 30,547 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-08-22 | 2023-08-24 | 855 | $174.88 | $149.5K | 31,052 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-08-22 | 2023-08-24 | 80 | $173.64 | $13.9K | 31,907 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2023-08-22 | 2023-08-24 | 1,500 | $9.20 | $13.8K | 31,987 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-08-08 | 2023-08-10 | 5,000 | — | $0 | 46,350 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-08-08 | 2023-08-10 | 2,500 | — | $0 | 22,177 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-08-08 | 2023-08-10 | 2,395 | $179.53 | $430.0K | 28,755 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-08-08 | 2023-08-10 | 2,500 | $5.45 | $13.6K | 26,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-08-08 | 2023-08-10 | 5,000 | $131.64 | $658.2K | 31,150 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-08-08 | 2023-08-10 | 1,355 | $180.93 | $245.2K | 27,400 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-08-08 | 2023-08-10 | 1,250 | $181.50 | $226.9K | 26,150 | SEC↗ |
| JONAS JEFFREY M | Director | M Exercise deriv | 2023-08-01 | 2023-08-02 | 13,810 | — | $0 | 33,702 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-08-01 | 2023-08-02 | 3,399 | $194.78 | $662.1K | 11,401 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-08-01 | 2023-08-02 | 6,301 | $195.61 | $1.23M | 5,100 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-08-01 | 2023-08-02 | 3,110 | $196.59 | $611.4K | 1,990 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-08-01 | 2023-08-02 | 400 | $197.66 | $79.1K | 1,590 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-08-01 | 2023-08-02 | 600 | $198.41 | $119.0K | 990 | SEC↗ |
| JONAS JEFFREY M | Director | M Exercise | 2023-08-01 | 2023-08-02 | 13,810 | $7.27 | $100.4K | 14,800 | SEC↗ |
| JONAS JEFFREY M | Director | M Exercise deriv | 2023-07-03 | 2023-07-05 | 13,810 | — | $0 | 47,512 | SEC↗ |
| OLSON LAURIE J | Director | M Exercise deriv | 2023-07-03 | 2023-07-05 | 1,000 | — | $0 | 13,000 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-07-03 | 2023-07-05 | 7,966 | $215.91 | $1.72M | 6,600 | SEC↗ |
| JONAS JEFFREY M | Director | M Exercise | 2023-07-03 | 2023-07-05 | 13,810 | $7.27 | $100.4K | 14,800 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-07-03 | 2023-07-05 | 234 | $214.61 | $50.2K | 14,566 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-07-03 | 2023-07-05 | 3,201 | $216.78 | $693.9K | 3,399 | SEC↗ |
| JONAS JEFFREY M | Director | S Sale | 2023-07-03 | 2023-07-05 | 2,409 | $217.82 | $524.7K | 990 | SEC↗ |
| OLSON LAURIE J | Director | M Exercise | 2023-07-03 | 2023-07-05 | 1,000 | $84.86 | $84.9K | 1,990 | SEC↗ |
| OLSON LAURIE J | Director | S Sale | 2023-07-03 | 2023-07-05 | 400 | $216.03 | $86.4K | 990 | SEC↗ |
| OLSON LAURIE J | Director | S Sale | 2023-07-03 | 2023-07-05 | 600 | $215.40 | $129.2K | 1,390 | SEC↗ |
| Torres Denice | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| OLSON LAURIE J | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| Pande Atul | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| JONAS JEFFREY M | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| HEALY JAMES | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| Torres Denice | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| OLSON LAURIE J | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| Pande Atul | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| JONAS JEFFREY M | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| HEALY JAMES | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 33,490 | SEC↗ |
| Wheadon David E. | Director | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| HEALY JAMES | Director | J Other | 2023-06-14 | 2023-06-20 | 8,025 | — | $0 | 8,025 | SEC↗ |
| HEALY JAMES | Director | J Other | 2023-06-14 | 2023-06-20 | 400,000 | — | $0 | 1,372,441 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2023-05-23 | 2023-05-25 | 9,000 | — | $0 | 94,726 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-05-23 | 2023-05-25 | 782 | $225.93 | $176.7K | 30,487 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2023-05-23 | 2023-05-25 | 9,000 | $9.20 | $82.8K | 39,487 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-05-23 | 2023-05-25 | 724 | $221.28 | $160.2K | 38,763 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-05-23 | 2023-05-25 | 2,093 | $222.24 | $465.1K | 36,670 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-05-23 | 2023-05-25 | 1,022 | $225.19 | $230.1K | 31,269 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-05-23 | 2023-05-25 | 1,070 | $224.19 | $239.9K | 32,291 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-05-23 | 2023-05-25 | 3,309 | $223.21 | $738.6K | 33,361 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | M Exercise deriv | 2023-04-20 | 2023-04-20 | 8,500 | — | $0 | 231,992 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | S Sale | 2023-04-20 | 2023-04-20 | 15,000 | $200.13 | $3.00M | 24,400 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | M Exercise | 2023-04-20 | 2023-04-20 | 8,500 | $9.20 | $78.2K | 39,400 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | M Exercise deriv | 2023-04-18 | 2023-04-20 | 30,000 | — | $0 | 240,492 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | S Sale | 2023-04-18 | 2023-04-20 | 30,000 | $200.16 | $6.00M | 30,900 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | M Exercise | 2023-04-18 | 2023-04-20 | 30,000 | $9.20 | $276.0K | 60,900 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-04-10 | 2023-04-12 | 5,000 | — | $0 | 6,362 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-04-10 | 2023-04-12 | 5,000 | $9.20 | $46.0K | 28,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-04-10 | 2023-04-12 | 5,000 | $176.88 | $884.4K | 23,650 | SEC↗ |
| OLSON LAURIE J | Director | M Exercise deriv | 2023-04-03 | 2023-04-05 | 1,000 | — | $0 | 14,000 | SEC↗ |
| OLSON LAURIE J | Director | S Sale | 2023-04-03 | 2023-04-05 | 1,000 | $181.02 | $181.0K | 0 | SEC↗ |
| OLSON LAURIE J | Director | M Exercise | 2023-04-03 | 2023-04-05 | 1,000 | $84.86 | $84.9K | 1,000 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-03-09 | 2023-03-09 | 5,000 | — | $0 | 24,677 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-03-09 | 2023-03-09 | 5,000 | $5.45 | $27.3K | 28,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-03-09 | 2023-03-09 | 5,000 | $189.51 | $947.5K | 23,650 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2023-02-21 | 2023-02-23 | 6,000 | — | $0 | 103,726 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-02-21 | 2023-02-23 | 6,000 | $190.01 | $1.14M | 30,487 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2023-02-21 | 2023-02-23 | 6,000 | $9.20 | $55.2K | 36,487 | SEC↗ |
| PAUL STEVEN M | CSO and President of R&D | A Award deriv | 2023-02-09 | 2023-02-13 | 22,800 | — | $0 | 22,800 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | A Award deriv | 2023-02-09 | 2023-02-13 | 25,100 | — | $0 | 25,100 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | A Award deriv | 2023-02-09 | 2023-02-13 | 17,350 | — | $0 | 17,350 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-02-09 | 2023-02-13 | 5,000 | — | $0 | 29,677 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | A Award deriv | 2023-02-09 | 2023-02-13 | 17,350 | — | $0 | 17,350 | SEC↗ |
| PAUL STEVEN M | CSO and President of R&D | A Award | 2023-02-09 | 2023-02-13 | 11,400 | — | $0 | 11,400 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | A Award | 2023-02-09 | 2023-02-13 | 12,550 | — | $0 | 30,900 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-02-09 | 2023-02-13 | 5,000 | $192.37 | $961.9K | 15,000 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | A Award | 2023-02-09 | 2023-02-13 | 8,650 | — | $0 | 23,650 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-02-09 | 2023-02-13 | 5,000 | $5.45 | $27.3K | 20,000 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | A Award | 2023-02-09 | 2023-02-13 | 8,650 | — | $0 | 30,487 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | A Award deriv | 2023-02-06 | 2023-02-07 | 29,937 | — | $0 | 29,937 | SEC↗ |
| Kane William P Jr | Chief Commercial Officer | A Award | 2023-02-06 | 2023-02-07 | 17,656 | — | $0 | 17,656 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2023-01-18 | 2023-01-19 | 200 | — | $0 | 109,726 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-01-18 | 2023-01-19 | 200 | $200.14 | $40.0K | 21,837 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2023-01-18 | 2023-01-19 | 200 | $9.20 | $1.8K | 22,037 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2023-01-17 | 2023-01-19 | 817 | — | $0 | 109,926 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2023-01-17 | 2023-01-19 | 817 | $9.20 | $7.5K | 22,654 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | S Sale | 2023-01-17 | 2023-01-19 | 817 | $201.41 | $164.6K | 21,837 | SEC↗ |
| HEALY JAMES | Director | S Sale | 2023-01-13 | 2023-01-17 | 6,027 | $199.90 | $1.20M | 0 | SEC↗ |
| HEALY JAMES | Director | J Other | 2023-01-12 | 2023-01-17 | 6,027 | — | $0 | 6,027 | SEC↗ |
| HEALY JAMES | Director | J Other | 2023-01-12 | 2023-01-17 | 300,000 | — | $0 | 1,772,441 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-01-09 | 2023-01-09 | 1,527 | — | $0 | 34,677 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2023-01-09 | 2023-01-09 | 3,473 | — | $0 | 0 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-01-09 | 2023-01-09 | 1,527 | $5.45 | $8.3K | 16,527 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-01-09 | 2023-01-09 | 3,473 | $197.52 | $686.0K | 15,000 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2023-01-09 | 2023-01-09 | 1,527 | $197.52 | $301.6K | 15,000 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2023-01-09 | 2023-01-09 | 3,473 | $7.27 | $25.2K | 18,473 | SEC↗ |
| Meury William | President and CEO | A Award deriv | 2023-01-03 | 2023-01-05 | 63,065 | — | $0 | 63,065 | SEC↗ |
| OLSON LAURIE J | Director | M Exercise deriv | 2023-01-03 | 2023-01-05 | 1,000 | — | $0 | 15,000 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 321 | $110.41 | $35.4K | 321 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 407 | $110.57 | $45.0K | 407 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 67 | $111.94 | $7.5K | 67 | SEC↗ |
| COUGHLIN CHRISTOPHER J | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 181 | $110.50 | $20.0K | 181 | SEC↗ |
| Meury William | President and CEO | A Award | 2023-01-03 | 2023-01-05 | 38,073 | — | $0 | 38,073 | SEC↗ |
| OLSON LAURIE J | Director | M Exercise | 2023-01-03 | 2023-01-05 | 1,000 | $84.86 | $84.9K | 1,000 | SEC↗ |
| OLSON LAURIE J | Director | S Sale | 2023-01-03 | 2023-01-05 | 1,000 | $197.48 | $197.5K | 0 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | M Exercise deriv | 2022-12-21 | 2022-12-22 | 7,100 | — | $0 | 47,817 | SEC↗ |
| Miller Andrew Craig | Chief Operating Officer | M Exercise | 2022-12-21 | 2022-12-22 | 7,100 | $2.92 | $20.7K | 18,350 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2022-12-16 | 2022-12-19 | 627 | — | $0 | 626 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2022-12-16 | 2022-12-19 | 371 | — | $0 | 8,559 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise deriv | 2022-12-16 | 2022-12-19 | 10,869 | — | $0 | 110,743 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2022-12-16 | 2022-12-19 | 10,869 | $9.20 | $100.0K | 20,839 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2022-12-16 | 2022-12-19 | 371 | $9.20 | $3.4K | 21,210 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | M Exercise | 2022-12-16 | 2022-12-19 | 627 | $9.20 | $5.8K | 21,837 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2022-12-09 | 2022-12-12 | 1,363 | — | $0 | 11,362 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise deriv | 2022-12-09 | 2022-12-12 | 3,637 | — | $0 | 3,473 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2022-12-09 | 2022-12-12 | 3,637 | $200.76 | $730.2K | 15,000 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | S Sale | 2022-12-09 | 2022-12-12 | 1,363 | $200.76 | $273.6K | 15,000 | SEC↗ |
| Brannan Stephen K. | Chief Medical Officer | M Exercise | 2022-12-09 | 2022-12-12 | 1,363 | $9.20 | $12.5K | 16,363 | SEC↗ |